New research has linked the genetic risk for schizophrenia to retinal thinning, suggesting early indicators of the disorder may be found in retinal morphology.

Promising data has been released for a drug candidate demonstrating “vision gains that were comparable and statistically non-inferior to aflibercept at week 36” in

CooperVision ANZ has expanded its warehouse facility in Torrensville, South Australia, marking a 65% increase in capacity to support continued growth across Australia and

Mark your diaries: O-Show, the boutique event known for bringing together the best in optical products and services for Australian and New Zealand practices,